Hellenic Accreditation System
|
|
|
- Amos Bryan
- 6 years ago
- Views:
Transcription
1 1 st Annex F1A/9 to the Certificate No Laboratory for Chemical Analysis of Medicines (ΕΦ), British Pharmacopoeia (BP), United States Pharmacopoeia (USP) and approved validated methods of product files Pharmaceutical starting materials and Test for related s of active High Performance Liquid Chromatography (HPLC) (UV-Vis) (MEE 9001) Spectrophotometry UV-Vis (MEE 9003) Identification of active Test for related s of active Thin Layer Chromatography (TLC) (MEE 9005) Assay of active Potentiometric determination of ph Titrimetry (use of indicator) (MEE 9006) General method EP of (ΜEΕ 9008) Page 1 of 9 1 st, 2 nd, 3 rd, 4 th,5 th and 6 th Annex F1/9 to the Certificate ESYD No
2 Single-dose Test for uniformity of content Semi-micro determination of water Physical tests General method EP using high performance liquid chromatography (HPLC) (UV-Vis) (MEE 9007) General method EP (MEE 9011) (ΕΦ), British Pharmacopoeia (BP), United States Pharmacopoeia (USP) and approved validated methods of product files Single-dose Test for uniformity of mass / Test for average mass General method EP by weighing (ΜΕΕ 9009) / specification product dossier Tablets and capsules Test for dissolution General method EP and assay of active with HPLC-(UV-Vis) or Spectrophotometry UV-Vis (MEE 9002) Test for disintegration General method EP (ΜΕΕ 9010) Site of asseseement : Permanent Laboratory premises, Mesogeion 284, Holargos, Athens Approved signatories : V. Violakis, E. Kyriakopoulou. The Accreditation Certificate No 244-4, to ELOT EN ISO/IEC 17025:2005, is valid until Director Laboratories Accreditation Division Page 2 of 9 1 st, 2 nd, 3 rd, 4 th,5 th and 6 th Annex F1/9 to the Certificate ESYD No
3 2 nd Annex F1B/9 to the Certificate No Microbiological Laboratory Microbiological tests (ΕΦ), British Pharmacopoeia (BP) and United States Pharmacopoeia (USP) Sterile and medical devices Sterility tests Test for bacterial endotoxins General method EP (MEE 7001) General methods EP, Method A (gel-clot: limit test) and Method B (gel-clot: semi-quantitative (MEE 7006) Non sterile and s for phaurmaceutical use Test for microbial quality General methods and EP (MEE 7002) Foodstuffs intended for particular nutritional uses Detection of Salmonella spp ISO 6579:2002 Detection of Enterobacter sakazakii ISO/TS 22964:2006 Site of asseseement : Permanent Laboratory premises, Mesogeion 284, Holargos, Athens Approved signatories : S. Gazi, V. Birtsas. Page 3 of 9 1 st, 2 nd, 3 rd, 4 th,5 th and 6 th Annex F1/9 to the Certificate ESYD No
4 The Accreditation Certificate No 244-3, to ELOT EN ISO/IEC 17025:2005, is valid until Director Laboratories Accreditation Division Page 4 of 9 1 st, 2 nd, 3 rd, 4 th,5 th and 6 th Annex F1/9 to the Certificate ESYD No
5 3 rd Annex F1C/9 to the Certificate No Section for Pharmacopoeia and Other Laboratory Standards (ΕΦ), British Pharmacopoeia (BP) and United States Pharmacopoeia (USP) Pharmaceutical starting materials and Assay of active Spectrophotometry UV-Vis, (MEE 9003) Titrimetry (use of indicator) (MEE 9006) High Performance Liquid Chromatography (HPLC) (UV-Vis) (MEE 9001) Site of asseseement : Permanent Laboratory premises, Mesogeion 284, Holargos, Athens Approved signatories : E. Georgiadou, A.Makritis The Accreditation Certificate No 244-4, to ELOT EN ISO/IEC 17025:2005, has been extended up to Director Laboratories Accreditation Division Page 5 of 9 1 st, 2 nd, 3 rd, 4 th,5 th and 6 th Annex F1/9 to the Certificate ESYD No
6 4 th Annex F1D/9 to the Certificate No Laboratory for Chemical Analysis of Feeding Stuffs, Dietary Products, Herbal Medicines (ΕΦ), British Pharmacopoeia (BP) and United States Pharmacopoeia (USP) and approved validated methods of product files Veterinary starting materials and formulations Assay of active Spectrophotometry UV-Vis (MEE 9003) Assay of active Titrimetry (use of indicator) (MEE 9006) Assay of active High Performance Liquid Chromatography (HPLC) (UV-Vis) Physical tests (ΕΦ), British Pharmacopoeia (BP) and United States Pharmacopoeia (USP) and approved validated methods of product files Single-dose formulations Test of uniformity of mass General method EP by weighing (ΜΕΕ 9009) Site of asseseement : Permanent Laboratory premises, Mesogeion 284, Holargos, ATHENS Approved signatories : A. Tsigouri, K.Fakinou. The Accreditation Certificate No 244-4, to ELOT EN ISO/IEC 17025:2005, is valid until Director Laboratories Accreditation Division Page 6 of 9 1 st, 2 nd, 3 rd, 4 th,5 th and 6 th Annex F1/9 to the Certificate ESYD No
7 5 th Annex F1E/9 to the Certificate No Biological and Toxicological Laboratory According to the monographs of current editions of Hellenic Pharmacopoeia (ΕΦ), British Pharmacopoeia (BP), United States Pharmacopoeia (USP) Pharmaceutical starting materials and Test for related s of active Physical tests Spectrophotometry UV-Vis (MEE 9003) Thin Layer Chromatography (TLC) (MEE 9005) According to the monographs of current editions of Hellenic Pharmacopoeia (ΕΦ), British Pharmacopoeia (BP), United States Pharmacopoeia (USP) Single-dose Test for uniformity of mass / Test for average mass General method EP by weighing (ΜΕΕ 9009) / specification product dossier Tablets and capsules Test for dissolution General method EP and assay of active with HPLC-(UV-Vis) or Spectrophotometry UV-Vis (MEE 9002) Tablets and capsules Test for disintegration General method EP (ΜΕΕ 9010) Page 7 of 9 1 st, 2 nd, 3 rd, 4 th,5 th and 6 th Annex F1/9 to the Certificate ESYD No
8 Site of asseseement : Permanent Laboratory premises, Mesogeion 284, Holargos, Athens Approved signatories : G.Volikakis The Accreditation Certificate No 244-4, to ELOT EN ISO/IEC 17025:2005, is valid until Director Laboratories Accreditation Division Page 8 of 9 1 st, 2 nd, 3 rd, 4 th,5 th and 6 th Annex F1/9 to the Certificate ESYD No
9 6 th Annex F1F/9 to the Certificate No Laboratory for Chemical Analysis of Cosmetics and Other Products Cosmetic Determination of 2-phenoxy-ethanol, methyl-, propyl-, and butyl-4- hydroxybenzoate (parabens) High performance liquid chromatographic (HPLC) method based on directive 96/45/EC (MEE-6005) Physical tests Medical gloves for single use Requirements and testing for freedom from holes ELOT EN 455-1:2000 Site of asseseement : Permanent Laboratory premises, Mesogeion 284, Holargos, Athens Approved signatories : S. Gazi. The Accreditation Certificate No 244-4, to ELOT EN ISO/IEC 17025:2005, is valid until Director Laboratories Accreditation Division Page 9 of 9 1 st, 2 nd, 3 rd, 4 th,5 th and 6 th Annex F1/9 to the Certificate ESYD No
WHO PUBLIC INSPECTION REPORT (WHOPIR) Quality Control Laboratory
SOP 408.4 Annex D 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int WHO PUBLIC INSPECTION REPORT (WHOPIR) Quality Control Laboratory Part
Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education
Ensuring Quality Pharmacy Compounding: Implications for Pharmaceutics Education Loyd V. Allen, Jr., Ph.D. Professor & Chair Emeritus University of Oklahoma HSC College of Pharmacy Editor-in in-chief International
Synergy Health Ireland Ltd.
IDA Business & Technology Park, Tullamore, Co.Offaly Testing Laboratory Registration number: 164T is accredited by the Irish National Board (INAB) to undertake testing as detailed in the Schedule bearing
Annex 1. Good pharmacopoeial practices
Annex 1 Good pharmacopoeial practices 1. Background 68 2. Purpose and scope of good pharmacopoeial practices 69 3. Glossary 69 4. Benefits of good pharmacopoeial practices 70 5. Implementation 70 6. Monograph
The Microbiological Requirements of a Stability Study. Ngoc Anh-Thu Phan 19 th June 2012
The Microbiological Requirements of a Stability Study Ngoc Anh-Thu Phan 19 th June 2012 Contents Introduction Harmonized Tests Acceptance Criteria Selection of Tests Why PE Testing? Selection of Category
Pharmacopoeial Reference Standards
Pharmacopoeial Reference Standards Industry view point Antony Raj Gomes Head- Quality Management 1 Presentation Overview Indian Industry an update Available guidelines Industry practices Current challenges
Annex A2. Guidance on Process Validation Scheme for Aseptically Processed Products
Annex A2 Guidance on Process Validation Scheme for Aseptically Processed Products 1 Table of content 1 PURPOSE... 3 2 SCOPE... 3 3 GENERAL INFORMATION... 3 4 INFORMATION NEEDED FOR ASEPTIC PROCESSES VALIDATION...
Identification of the need and uses of a reference standard
Identification of the need and uses of a reference standard Stefan Almeling Deputy Head of Laboratory Department, EDQM, Council of Europe TOPICS General / Definition Role in the monograph How established
Salient Features of IP-2010 (VI edition)
Salient Features of IP-2010 (VI edition) By:- Dr. Raman Mohan Singh Principal Scientific Officer, IPC-IPL, IPL, Ghaziabad. Website: www.ipc.gov.in Email: ipclab@vsnl.net As per the Drugs and Cosmetics
Specifications, Methods and precedence of source with particular reference to microbiological requirements in TGOs.
Specifications, Methods and precedence of source with particular reference to microbiological requirements in TGOs. Fergus O Connell RACI Pharmaceutical Science Group (NSW) 10/08/2015 Currently there are
SCOPE OF ACCREDITATION TO ISO/IEC 17025:2005. Q LABORATORIES, INC Harrison Avenue Cincinnati, OH David Goins Phone:
SCOPE OF ACCREDITATION TO ISO/IEC 17025:2005 1400 Harrison Avenue Cincinnati, OH 45214 David Goins Phone: 513-471-1300 BIOLOGICAL Valid To: July 31, 2018 Certificate Number: 3026.02 In recognition of the
A GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Pharmaceuticals and cosmetics Final Revision 0 NOTICE TO APPLICANTS A GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999 This guideline
Management Team. Over 35 years experience in the pharmaceuticals industry
2017 1 Overview Located in Bangalore, a Dedicated cgmp and cglp Compliance Laboratory Established in September 2010 Approved Contract research Organization by India FDA Approved by Health Canada since
STS Directory Accreditation number: STS 0268
International standard: ISO/IEC 17025:2005 Swiss standard: SN EN ISO/IEC 17025:2005 Bioexam AG Maihofstrasse 95a P.O.B. 6858 CH-6000 Lucerne 6 Head: Candid Bucher Responsible for MS: Nathalie Amstein Telephone:
Table S3: Risk of bias in the included observational studies
Table S3: Risk of bias in the included observational studies Study Name, Funding Abdoulaye, Chastanier,Azondekon et al, 2006[24] Bate and Mathur, 2011[38] Developing and applying appropriate eligibility
Comments concerning revised texts published in Supplement 9.5
Pharmeuropa Useful information December 2017 1 Comments concerning revised texts published in Supplement 9.5 The following information details the technical modifications that have been made to revised
DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE
DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION FOR A SPECIFIED IMPURITY IN A NEW DRUG SUBSTANCE Determine impurity level in relevant batches 1 Determine mean + upper confidence limit for the impurity
Content of the dossier for chemical purity and microbiological quality
Division Certification of Substances CP/CB PUBLIC DOCUMENT (Level 1) English only/anglais seulement PA/PH/ CEP (0) 1 R February 0 Certification of suitability of Monographs of the European Pharmacopoeia
European Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe
European Pharmacopoeia Reference Standards A Lodi, Head of the Laboratory Department, EDQM, Council of Europe Content Ph. Eur. Reference Standards General notices, terms and definitions Key attributes
INNOVATIVE COMPOUNDING SERVICES
INNOVATIVE COMPOUNDING SERVICES We are excited to introduce our innovative compounded oral rinses that may offer a safe and effective alternative for the management of side effects associated with chemotherapy
TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR NEW VETERINARY DRUG SUBSTANCES AND NEW MEDICINAL PRODUCTS: CHEMICAL SUBSTANCES
VICH GL39 (QUALITY) November 2005 For implementation at Step 7 TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR NEW VETERINARY DRUG SUBSTANCES AND NEW MEDICINAL PRODUCTS: CHEMICAL SUBSTANCES Recommended for
Inspection of Quality Control Laboratories
Inspection of Quality Control Laboratories PQP Manufacturer's Meeting April 4-5 th 2011, Geneva, Switzerland Stephanie Croft, M.Sc. Technical Officer (Inspector), WHO Prequalification of Medicines Programme
CERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION ANSI-ASQ National Accreditation Board 500 Montgomery Street, Suite 625, Alexandria, VA 22314, 877-344-3044 This is to certify that UL Verifications Services, Inc. 85 John Road
COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE:
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit - FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE: DEVELOPMENT PHARMACEUTICS FOR VETERINARY
Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C.
Best Practices and Application of GMPs for Small Molecule Drugs in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Specifications Breakout Session 2 Pete Yehl and Mike Coutant, moderators
STANDARD OPERATING PROCEDURES. Handling and working with Analytical Standards
Page: 1 of 6 1.Purpose The purpose of this Standard Operating Procedure is to establish a standardized procedure of using United States Pharmacopoeia (USP) standards, detailing the procedure of qualification,
APPLICATION FOR VARIATION TO A MARKETING AUTHORISATION
Page 1 of 13 May 2008 APPLICATION FOR VARIATION TO A MARKETING AUTHORISATION HUMAN VETERINARY NATIONAL AUTHORISATION IN MRP MRP variation number 1A : / / / / / COMMUNITY AUTHORISATION EMEA variation number
Public Assessment Report. Scientific discussion. Lacidipine Double-e Pharma 2 mg, 4 mg and 6 mg film-coated tablets. (lacidipine)
Public Assessment Report Scientific discussion Lacidipine Double-e Pharma 2 mg, 4 mg and 6 mg film-coated tablets (lacidipine) NL/H/2992/001-003/DC Date: 28 July 2016 This module reflects the scientific
PHARMA KNOWLEDGE PARK
GUIDELINES 2013 WWW.NOORMD.COM A COMPILATION BY ON PHARMACEUTICAL REGULATORY GUIDELINES INTRODUCED / REVISED DURING THE YEAR 2013. Page 2 ICH Assessment and control of DNA reactive (mutagenic) impurities
Guideline on requirements for the production and control of immunological veterinary medicinal products
14 June 2012 EMA/CVMP/IWP/206555/2010 Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on requirements for the production and control of immunological veterinary Draft agreed by Immunologicals
Public Assessment Report. Scientific discussion. Naproxennatrium Banner 220 mg capsules, soft (naproxen sodium) NL/H/2804/001/DC. Date: 28 April 2014
Public Assessment Report Scientific discussion Naproxennatrium Banner 220 mg capsules, soft (naproxen sodium) NL/H/2804/001/DC Date: 28 April 2014 This module reflects the scientific discussion for the
Guidance Document 01 January 2016 CONTENTS. 1. Introduction Background 1.2. Objectives 1.3. Scope and application 1.4 APIMF holder obligations
GUIDANCE ON AMENDMENTS TO AN ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) SUBMITTED IN SUPPORT OF A PREQUALIFIED PHARMACEUTICAL PRODUCT (FPP) OR PREQUALIFIED ACTIVE PHARMACEUTICAL INGREDIENT (API)
Appendices! Product quality documents. Technical guidelines. (Translation from Original Chinese Version)
Appendices! (Translation from Original Chinese Version) Product quality documents Technical guidelines Appendix I General tests for various dose forms of pcms The general tests for various dose forms of
Xylose Lysine Deoxycholate (XLD) Agar LI acc. EP/USP
Technical Data Sheet Xylose Lysine Deoxycholate (XLD) Agar LI acc. EP/USP Ordering number: 1.46073.0020 / 1.46073.0120 Xylose Lysine Deoxycholate (XLD) Agar LI is a selective culture medium for isolation
Preservative Challenge Testing and Compendia: Efficient Efficacy
Preservative Challenge Testing and Compendia: Efficient Efficacy October 28, 2014 Leon Nepomniashy Energizer Personal Care Presentation Agenda I. Preservative Efficacy overview The What, The When and The
Microbiological Consideration for Non-Sterile Pharmaceutical
May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control
Public Assessment Report. Scientific discussion. Kruidvat Paracetamol liquid caps 500 mg, soft capsules. (paracetamol) NL License RVG:
Public Assessment Report Scientific discussion Kruidvat Paracetamol liquid caps 500 mg, soft capsules (paracetamol) NL License RVG: 116359 Date: 10 April 2017 This module reflects the scientific discussion
Comments concerning revised texts published in Supplement 9.4
Pharmeuropa Useful information October 2017 1 Comments concerning revised texts published in Supplement 9.4 The following information details the technical modifications that have been made to revised
Need and Application of Analytical Method Development on New Fixed Dose Combination of Irbesartan and Atorvastatin in Pharmaceutical Industry
43 Review Article Need and Application of Analytical Method Development on New Fixed Dose Combination of Irbesartan and Atorvastatin in Pharmaceutical Industry Paras Virani 1,2 *, Parul Jain 3, Hasumati
OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT
OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT PA/PH/OMCL (13) 113 2R Evaluation and Reporting of Results Core document Full document title and reference Evaluation and Reporting of Results
FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS La Haute Marche Javené BP FOUGERES cedex FRANCE
FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS La Haute Marche Javené BP 90203 35302 FOUGERES cedex FRANCE DECENTRALISED PROCEDURE FOR A VETERINARY MEDICINAL PRODUCT EIMERYL, 200 MG/ML SOLUTION FOR USE
EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible
GUIDELINES FOR SUBMISION OF POST- APPROVAL VARIATION MEDICINE APPLICATIONS
GUIDELINES FOR SUBMISION OF POST- APPROVAL VARIATION MEDICINE APPLICATIONS FOOD, MEDICINE AND HEALTH CARE ADMINSTRATION AND CONTROL AUTHORITY OF ETHIOPIA (EFMHACA) First Edition December, 2015 Table of
Comments concerning revised texts published in Supplement 9.3
Pharmeuropa Useful information June 2017 1 Comments concerning revised texts published in Supplement 9.3 The following information details the technical modifications that have been made to revised texts
Cooperation in the field of toxicology, analytics, R&D and production
Cooperation in the field of toxicology, analytics, R&D and production Where you can find us 2 2 VUOS PARTNER FOR COOPERATION History 3 3 VUOS PARTNER FOR COOPERATION Organizational structure 1. R&D and
Flexible and Pending Monographs
Flexible and Pending Monographs USP Approaches to Accommodate Multiple Approved Products Doreen McDonald Senior National Account Manager U.S. Pharmacopeial Convention Flexible Monographs: Background From
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 25 October 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU
Documentation requirements for an initial consultation
Language : French or English Documentation requirements for an initial consultation Because of the wide range of medical devices which incorporate, as an integral part, an ancillary medicinal substance,
Accredited Laboratory A2LA has accredited WUXI APPTEC, INC. Marietta, GA for technical competence in the field of
Accredited Laboratory A2LA has accredited Marietta, GA for technical competence in the field of Biological Testing This laboratory is accredited in accordance with the recognized International Standard
Update to USP <621> Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014
Update to USP Chromatography: What does this mean? USP 37 NF 32 1S Current as of August 2014 2015 Waters Corporation 1 What is the USP-NF? The United States Pharmacopeia National Formulary (USP-NF)
ACCREDITED AND RECOGNIZED AUDIT & CERTIFICATION SERVICES BY TÜV AUSTRIA TÜV AUSTRIA HELLAS
ACCREDITED AND RECOGNIZED AUDIT & CERTIFICATION SERVICES BY TÜV AUSTRIA TÜV AUSTRIA HELLAS ACCREDITATIONS & RECOGNITIONS QUALITY ISO 9001 Quality Management Systems ΕLΟΤ 1429 (TYPE Α, B and C) - National
Overview of USP Activities and How to Get Involved
Overview of USP Activities and How to Get Involved Ravi Ravichandran, Ph.D. Principal Scientific Liaison, Chemical Medicines United States Pharmacopeia Outline Introduction to the USP USP Standard Setting
Evaluation of rice husk as an excipient for the pharmaceutical industry
Evaluation of rice husk as an excipient for the pharmaceutical industry Fernández_Ledesma E. 1, Rodríguez _Acosta C. 1, Liva_Garrido M. 2, Díaz_ Polanco I. 3, Cazanave_Guarnaluce D. 3 1 Engineering and
Quality is Our Promise.
Quality is Our Promise. Our goal at KRS Global Biotechnology is to provide the highest quality pharmaceutical preparations. We accomplish this with an unrivaled quality assurance and quality control program
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union
Ref. Ares(2014)968036-28/03/2014 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, 28 March 2014 EudraLex
EDQM Overview of our products and services
EDQM Overview of our products and services Guide to the Quality and Safety of Organs for Transplantation EDQM 6th Edition 2016 2017 www.edqm.eu www.edqm.eu/store CombiStats : statistical analysis software
Microbial Contamination Testing and Validation Challenges Non-Sterile Products and Raw Materials
Microrite, Inc. brings you this unique learning experience in Microbial Contamination Testing and Validation ; Part of Microrite s step-by-step webinar series. Microbial Contamination Testing and Validation
MEDIS INTERNATIONAL a.s Praha 1, Olivova 4/2096 MEDIS PHARMA Bolatice. Industrial zone Bolatice, region of Opava, Czech Republic
MEDIS INTERNATIONAL a.s. 110 00 Praha 1, Olivova 4/2096 MEDIS PHARMA Bolatice Industrial zone Bolatice, region of Opava, Czech Republic In October 2008 MEDIS International a.s. started the building of
Public Assessment Report. Scientific discussion. Tranexaminezuur Sandoz 100 mg/ml, solution for injection. (tranexamic acid) NL/H/3153/001/DC
- C Public Assessment Report Scientific discussion Tranexaminezuur Sandoz 100 mg/ml, solution for injection (tranexamic acid) NL/H/3153/001/DC Date: 18 March 2015 This module reflects the scientific discussion
Validation of Thin Layer Chromatographic Procedures
Validation of Thin Layer Chromatographic Procedures International Symposium for High-Performance Thin-Layer Chromatography HPTLC 2011 July 7th, 2011, Basle Topics ICH Q2(R1) and nothing else? Other guidance
EU and FDA GMP Regulations: Overview and Comparison
THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational
Guide to the investigational medicinal product dossier
Guide to the investigational medicinal product dossier Item type Authors Publisher Other Irish Medicines Board (IMB) Irish Medicines Board (IMB) Downloaded 1-May-2018 07:31:12 Link to item http://hdl.handle.net/10147/96980
GMP MANUAL Contents. 1 Pharmaceutical Quality System (PQS)
GMP MANUAL GMP MANUAL 1 Pharmaceutical Quality System (PQS) 1.A Preface 1.B The road to a Pharmaceutical Quality System 1.C Introduction to the PQS 1.C.1 General requirements 1.C.2 Documentation 1.D Main
Good manufacturing practices
The rules governing medicinal products in the European Union Volume 4 Good manufacturing practices Medicinal products for human and veterinary use 1998 Edition EUROPEAN COMMISSION Directorate General III
SCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredients (APIs): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:
International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW
International Journal of Pharma and Bio Sciences DEVELOPMENT OF ACCELERATED STABILITY PROTOCOL FOR SILDENAFIL TABLETS A EUROPEAN PERSPECTIVE REVIEW SUKHDEV SINGH *1 AND JASBIR SINGH 2 1 Rayat Institute
11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS. Siriphorn Laomanacharoen 21 December 2012
11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS Siriphorn Laomanacharoen 21 December 2012 11 th INTERNATIONAL SYMPOSIUM ON PHARMACEUTICAL REFERENCE STANDARDS Organised by European Directorate
European Medicines Agency Inspections
European Medicines Agency Inspections London, 31 March 2006 CHMP/QWP/185401/2004 final COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE REQUIREMENTS TO THE CHEMICAL AND PHARMACEUTICAL
Master of Life & Health Sciences in Drug Sciences Speciality in Drug and Food Quality (EuroDaFQ) Head: Pr S. MICHEL
Master of Life & Health Sciences in Drug Sciences Speciality in Drug and Food Quality (EuroDaFQ) Head: Pr S. MICHEL sylvie.michel@parisdescartes.fr The Master course is designed to provide a 2-year education
GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE
GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Finished Pharmaceutical Product Questionnaire This questionnaire is used to collect information from vendors with regards to finished pharmaceutical products
Session 5: Increase in Use of the WHO Prequalification Programme
Session 5: Increase in Use of the WHO Prequalification Programme Perceived Need for Prequalification In an ideal world: Regulated pharmacies and service providers would supply medicines to clients Regulatory
Public Assessment Report. Scientific discussion. Pantoprazole ADOH 40 mg, powder for solution for injection. (pantoprazole sodium sesquihydrate)
Public Assessment Report Scientific discussion Pantoprazole ADOH 40 mg, powder for solution for injection (pantoprazole sodium sesquihydrate) NL/H/3656/001/DC Date: 10 April 2017 This module reflects the
GUIDANCE ON VARIATIONS TO A PREQUALIFIED DOSSIER
RESTRICTED GUIDANCE ON VARIATIONS TO A PREQUALIFIED DOSSIER Since being presented to the Fortieth meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations in October 2005 this
INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON ARTEMETHER AND LUMEFANTRINE CAPSULES REVISED DRAFT FOR DISCUSSION
October 2007 RESTRICTED ` INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON ARTEMETHER AND LUMEFANTRINE CAPSULES REVISED DRAFT FOR DISCUSSION World Health Organization 2007 All rights reserved. This draft is intended
Republic of the Philippines Department of Health OFFICE OF THE SECRETARY M a n i l a
Republic of the Philippines Department of Health OFFICE OF THE SECRETARY M a n i l a March 15, 1989 ADMINISTRATIVE ORDER No. 67 s. 1989 SUBJECT: Revised Rules and Regulations on Registration of Pharmaceutical
Elemental impurities and their measurement. a: 119 Magowar Rd, Girraween 2145 p: (02) f: (02)
Elemental impurities and their measurement A change is on its way. The new millennium has brought with it a rethink of the approach to heavy metals testing in pharmaceuticals. In addition to the simple
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE GUIDELINES INDEX
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE GUIDELINES INDEX BATCH Q: Quality Q1A(R2) Stability Testing of New Drug Substances
WHO GENERAL GUIDANCE ON VARIATIONS TO MULTISOURCE PHARMACEUTICAL PRODUCTS. (February 2014)
February 2014 Draft for comment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 World Health Organization 2014 All rights reserved.
ISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 8871-4 First edition 2006-06-15 Elastomeric parts for parenterals and for devices for pharmaceutical use Part 4: Biological requirements and test methods Éléments en élastomère
Latest USP Initiatives: Monographs, General Chapters, and Compounding
Latest USP Initiatives: Monographs, General Chapters, and Compounding Jim Ponto, MS, RPh, BCNP Disclosures Volunteer member on several USP Expert Committees and Expert Panels associated with radiopharmaceutical
The European Approach on Large Sample Sizes in the context of a PAT Environment
The European Approach on Large Sample Sizes in the context of a PAT Environment Dr. Michael Wierer, Deputy Head, European Pharmacopoeia Department, European Directorate for the Quality of Medicines & HealthCare
GUIDANCE FOR QUALITY ASSESSORS DRUG SUBSTANCE. IGDRP Quality Working Group
GUIDANCE FOR QUALITY ASSESSORS DRUG SUBSTANCE IGDRP Quality Working Group Version Description of Change Author Effective Date v 1.0 Original publication Quality WG June 8, 2017 Foreword In order to achieve
for IND and RDRC Regulated PET Compounding
Overview of USP Chapter for IND and RDRC Regulated PET Compounding Distributed Manufacturing of PET Radiopharmaceuticals for Multi-Center Clinical Trials SNM, Annual Meeting Toronto, Ontario, Canada
USP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
Actavis Italy. Nerviano Plant
Actavis Italy Nerviano Plant Starting out in 1901 in Jerusalem The company known today as Teva was established as a small wholesale drug business by Chaim Salomon, Moshe Levin and Yitschak Elstein. (They
Guideline on setting specifications for related impurities in antibiotics
1 2 3 4 14 July 2010 EMA/CHMP/CVMP/QWP/199250/2009 Committee for Medicinal Products for Human Use (CHMP) / Committee for Medicinal Products for Veterinary Use (CVMP) 5 6 7 Guideline on setting specifications
Ergometrine Inj. 500mcg 1ml x 10 amps A005223
Our Sign: ROSSA date Material description: Batch hameln: Ergometrine Inj. 500mcg 1ml x 10 amps 0007543800 For the pharmaceutical preparation shipped to you herewith you receive the documents attached.
Quality Assessment & GMP Similarities & Differences
Quality Assessment & GMP Similarities & Differences EMEA, Monday 26 th October 2009 Cormac Dalton Inspector Irish Medicines Board Date 12-Oct-09 Slide 1 Content Overview of commonalities & differences
ADVANCED TESTING LABORATORY
RESOLVING ISSUES. REDUCING RISK. ADVANCED TESTING LABORATORY PROVIDING PEACE-OF-MIND. ADVANCED TESTING LABORATORY 6954 Cornell Road Cincinnati, OH 45242 513.489.8447 513.489.9291 fax ClientRelations@advancedtesting.net
Certificate of Analysis
Certificate of Analysis ISO GUIDE 34 AAB Cert# AR-1470 ISO/IEC 17025 AAB Cert# AT-1467 FLUCOAZOLE CERTIFIED REFERECE MATERIAL F OH F CERTIFIED PURITY: 99.6%, U crm = ±0.2% k = 2 (Mass Balance/as is basis)
EXOVA (Ireland) Ltd.
EXOVA (Ireland) Ltd. Glanmire Industrial Estate, Glanmire, Co. Cork. Testing Laboratory Registration number: 183T is accredited by the Irish National Board (INAB) to undertake testing as detailed in the
Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL
Balancing the time, cost and risk of drug development Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL Communicating vessels Risk Time Cost Communicating vessels
HEALTH DEPARTMENT. On the margin, a seal bearing the national symbol and the words United Mexican States Health Department.
Wednesday, January 4, 2006 OFFICIAL GAZETTE (Second Section) 1 HEALTH DEPARTMENT Official Mexican Standard NOM-073-SSA1-2005, Stability of Drugs and Medicine (modifies the NOM-073-SSA1-1993, Stability
Public Assessment Report. Scientific discussion. Pregamid 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg hard capsules.
Public Assessment Report Scientific discussion Pregamid 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg hard capsules (pregabalin) NL/H/3245/001-008/DC Date: 27 July 2016 This module reflects
Guidance for Industry
Guidance for Industry ANDAs: Impurities in Drug Products DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should
CERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION ANSI-ASQ National Accreditation Board/ACLASS 500 Montgomery Street, Suite 625, Alexandria, VA 22314, 877-344-3044 This is to certify that Molecular Epidemiology, Inc. (MEI)
Public Health Microbiology Lab. Cork Integrated Service Area(ISA), HSE South
Public Health Microbiology Lab. Cork Integrated Service Area(ISA), HSE South St. Finbarr s Hospital, Douglas Road, Cork Testing Laboratory Registration number: 087T is accredited by the Irish National
Process Validation Guidelines. by Pramote Cholayudth Thai Industrial Pharmacist Association (TIPA)
Process Validation Guidelines by Pramote Cholayudth cpramote2000@yahoo.com Thai Industrial Pharmacist Association (TIPA) September 19, 2016 1 2 Process Validation References Hierarchy Law Regulatory Guidelines
Certifications: Table of Contents. Document # Title Page(s)
Certifications: Table of Contents Document # Title Page(s) 1 ISO 17025: Certificate of Accreditation 2 2 ISO 17025: Scope of Accreditation 3-6 3 FDA: Medical Device Establishment 7 Registration 4 FDA: